GLP-1 medications have helped many individuals achieve results that previously felt out of reach, but they work best when integrated into a comprehensive strategy focused on nutrition, exercise, metabolic health, and long-term sustainability
Many patients with type 2 diabetes also have cardiovascular comorbidities requiring beta blocker therapy
Different bodies, doses, and starting points produce different curves that often converge by the end anyway
Wegovy pens, which are the same semaglutide molecule but marketed specifically for weight loss, come in single-dose pens that deliver 0.25mg, 0.5mg, 1mg, 1.7mg, or 2.4mg with no dose adjustment required
Some bodies simply need more time to feel safe letting go of weight
Common side effects relating to sitagliptin include: Infections of the upper respiratory tract Headaches More infrequently, Sitagliptin is associated with abdominal pain, nausea and diarrhoea